Trial Profile

An Open Label, Single Arm Clinical Study of Intravitreal Injection of Conbercept in Patients With Maculae Edema Secondary to Retinal Vein Occlusion (the FALCON Study)

Status: Completed

Phase of Trial: Phase II

Latest Information Update: 31 Jan 2019

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Conbercept (Primary)
Indications Retinal oedema
Focus Therapeutic Use
Acronyms FALCON
Sponsors Chengdu Kanghong Biotech

Most Recent Events

22 Jan 2018 Sponsor association:However, the company tool also have added Chengdu Kanghong Biotech as a subsidiary of Chengdu Kanghong Pharmaceuticals. I have tagged Chengdu Kanghong Biotech as the sponsor to represent the details similar to CT.gov record.
01 Sep 2017 Status changed to completed, according to results published in the Retina Journal.
01 Sep 2014 New trial record

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com